GlucoTrack (GCTK) Announces 1:20 Reverse Share Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Glucotrack Announces Reverse Stock Split
January 30, 2025 8:00 AM EST1-for-20 reverse stock split to become effective as of the opening of trading on February 4, 2025
RUTHERFORD, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (Glucotrack or the Company), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will effect a 1-for-20 reverse stock split (the Reverse Stock Split) of its issued and outstanding common stock par value $0.001 per share (the Common Stock), effective with the opening of trading on Tuesday, February 4, 2025.
Glucotracks... More
